Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07174401
PHASE4

Rocklatan Retinal Perfusion OCT Study

Sponsor: Oregon Health and Science University

View on ClinicalTrials.gov

Summary

The main purpose of this study is to learn more about how Rocklatan eye drops affects blood flow in the eye. The secondary purpose is to see if our study devices can detect changes in blood flow before and after instillation of Rocklatan.

Official title: Rocklatan Trial With Optical Coherence Tomography Study of Retinal Perfusion

Key Details

Gender

All

Age Range

21 Years - Any

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2026-01

Completion Date

2027-10

Last Updated

2025-12-24

Healthy Volunteers

No

Conditions

Interventions

DRUG

Rocklatan eye drops will be instilled nightly in one eye diagnosed with glaucoma for up to 12 months.

The eye not selected as the study eye will be used for comparison so both eyes will be imaged with the study devices to assess blood flow changes.

DEVICE

Two optical coherence tomography (OCT) devices will be used to assess blood flow changes.

One OCT device is FDA-cleared while the other is still experimental. Both devices assess blood flow in different ways.

Locations (1)

Casey Eye Institute - Oregon Health & Science University

Portland, Oregon, United States